3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
8
Breast Neoplasms
7
Prostatic Neoplasms
6
Lung Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Urinary Bladder Neoplasms
5
Glioma
5
Astrocytoma
5
Oropharyngeal Neoplasms
4
Esophageal Neoplasms
4
Carcinoma
4
Burkitt Lymphoma
4
Squamous Cell Carcinoma of Head and Neck
3
Sarcoma
3
Rectal Neoplasms
3
Neoplasm Metastasis
3
Adenocarcinoma of Lung
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Sarcoma, Ewing
2
Pancreatic Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Mesothelioma, Malignant
2
Melanoma
2
Liposarcoma
2
Laryngeal Neoplasms
2
Hodgkin Disease
2
Gliosarcoma
2
Ganglioneuroblastoma
2
Interventions
venetoclax
6
ibrutinib
4
pirtobrutinib
2
Sirolimus
2
Rituximab
2
Mycophenolic Acid
2
Cyclosporine
2
Cyclophosphamide
2
zanubrutinib
1
pembrolizumab
1
loncastuximab tesirine
1
fludarabine phosphate
1
carfilzomib
1
acalabrutinib
1
Whole-Body Irradiation
1
Tacrolimus
1
Specimen Handling
1
Rifaximin
1
Peripheral Blood Stem Cell Transplantation
1
Methotrexate
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Etoposide
1
Dexamethasone
1
Cyclosporins
1
Calcium Dobesilate
1
CT-P10
1
Busulfan
1
Biopsy
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Waldenstrom Macroglobulinemia
×
Radiation
×
30 days
×
Clear all
No trials found.